TechNavio today launched its report Human Insulin Market in China 2011-2015 based on an in-depth study focusing exclusively on China. The report aims to aid decision makers’ understanding of the present and future landscape of the market.
Commenting on the report, an analyst from TechNavio’s Healthcare team said; ”The Human Insulin market in China has recently been witnessing a significant increase in the number of corporate agreements between global and regional vendors, which increases the competition in the market. In addition to the corporate agreements, the Human Insulin market in China is experiencing significant focus on innovation and product development.”
According to the report, one of the major growth factors driving the Human Insulin market in China is the significant increase in the number of patients suffering from diabetes and diabetes-related diseases in the country.
Further, the report also discusses that one of the major challenges is the high cost of the human insulin that is provided mainly by the leading vendors in China.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key players.
TechNavio, the market research platform of Infiniti Research Ltd, publishes periodic reports on niche and emerging technologies. For further information, please visit http://goo.gl/49dCh
Follow us on Twitter @ Technavio
TechNavio Announces the Publication of its Report – Human Insulin Market in China 2011-2015
